OXANDROLONOS Pharmaceutical

£66.00

OXANDROLONOS Pharmaceutical is an oral anabolic steroid compound extensively studied in laboratory research for its unique molecular properties and tissue-selective activity in controlled experimental settings.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
OXANDROLONOS Pharmaceutical
OXANDROLONOS Pharmaceutical
£66.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Product Overview: OXANDROLONOS Pharmaceutical

OXANDROLONOS Pharmaceutical is an oral anabolic steroid compound derived from dihydrotestosterone that has been extensively investigated in laboratory research settings. This synthetic derivative exhibits unique molecular characteristics that make it valuable for in-vitro studies examining androgen receptor interactions and protein synthesis pathways. Research institutions frequently analyse this compound’s distinctive 17α-alkylated structure, which provides oral bioavailability in experimental models while maintaining tissue-selective properties that differentiate it from other androgenic compounds.

Scientists at Stroid UK Shop study this pharmaceutical-grade compound alongside other research materials including selective androgen receptor modulators to understand comparative mechanisms of action. The compound’s molecular formula C19H30O3 represents modifications that researchers examine when investigating structure-activity relationships in androgenic steroid chemistry. Laboratory studies have focused on this compound’s low androgenic rating compared to its anabolic properties, making it an important reference standard in comparative endocrinology research.

Laboratory Research Applications

Research scientists investigate OXANDROLONOS for its effects on nitrogen retention and protein synthesis in cellular models. Studies examine how this compound influences gene expression patterns related to muscle protein synthesis pathways, particularly through its interaction with androgen receptors. Researchers analyse its impact on IGF-1 production and examine its role in phosphocreatine synthesis within muscle tissue samples. Laboratory investigations focus on the compound’s influence on collagen synthesis, which makes it relevant for research into connective tissue biology.

Comparative studies evaluate this compound against other research chemicals in the oral steroid category to understand its unique pharmacological profile. Research teams examine its hepatic metabolism patterns and investigate how its 17α-alkylation affects liver enzyme interactions in controlled laboratory conditions. Scientists study its effects on lipid metabolism, particularly examining changes in HDL and LDL cholesterol levels in experimental models. Additional research focuses on the compound’s influence on bone density markers and calcium metabolism pathways, alongside investigations conducted with peptide research compounds.

Product Specifications

OXANDROLONOS Pharmaceutical Research Specifications
Parameter Specification
CAS Number 53-39-4
Molecular Formula C19H30O3
Molecular Weight 306.44 g/mol
Purity Verify with supplier
Storage Room temperature, dry environment
Physical State Solid crystalline powder

Research Use Compliance

OXANDROLONOS Pharmaceutical is supplied exclusively for in-vitro laboratory research purposes by qualified scientific institutions. This research chemical is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper licensing and institutional approval before conducting studies with this compound. All investigations should follow established laboratory safety protocols and regulatory guidelines for handling research chemicals. Purchase and use are restricted to legitimate research applications only.

Related